These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25641908)

  • 1. Lysine conjugation properties in human IgGs studied by integrating high-resolution native mass spectrometry and bottom-up proteomics.
    Gautier V; Boumeester AJ; Lössl P; Heck AJ
    Proteomics; 2015 Aug; 15(16):2756-65. PubMed ID: 25641908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Campuzano IDG; Netirojjanakul C; Nshanian M; Lippens JL; Kilgour DPA; Van Orden S; Loo JA
    Anal Chem; 2018 Jan; 90(1):745-751. PubMed ID: 29193956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl Labeling Coupled with Mass Spectrometry for Topographical Characterization of Primary Amines on Monoclonal Antibodies.
    Jhan SY; Huang LJ; Wang TF; Chou HH; Chen SH
    Anal Chem; 2017 Apr; 89(7):4255-4263. PubMed ID: 28257187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
    Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
    J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of in vivo drug load distribution of cysteine-linked antibody-drug conjugates using microscale liquid chromatography mass spectrometry.
    Hengel SM; Sanderson R; Valliere-Douglass J; Nicholas N; Leiske C; Alley SC
    Anal Chem; 2014 Apr; 86(7):3420-5. PubMed ID: 24576206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative collision-induced unfolding differentiates model antibody-drug conjugates.
    Tian Y; Lippens JL; Netirojjanakul C; Campuzano IDG; Ruotolo BT
    Protein Sci; 2019 Mar; 28(3):598-608. PubMed ID: 30499138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation Site Analysis of Lysine-Conjugated ADCs.
    Sang H; Wan N; Lu G; Tian Y; Wang G; Ye H
    Methods Mol Biol; 2020; 2078():235-250. PubMed ID: 31643061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry.
    Sang H; Lu G; Liu Y; Hu Q; Xing W; Cui D; Zhou F; Zhang J; Hao H; Wang G; Ye H
    Anal Chim Acta; 2017 Feb; 955():67-78. PubMed ID: 28088282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization.
    Terral G; Beck A; Cianférani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():79-90. PubMed ID: 27108304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An accurate TMT-based approach to quantify and model lysine susceptibility to conjugation via N-hydroxysuccinimide esters in a monoclonal antibody.
    Hill JJ; Tremblay TL; Corbeil CR; Purisima EO; Sulea T
    Sci Rep; 2018 Dec; 8(1):17680. PubMed ID: 30518942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-Specific Conjugation to Native and Engineered Lysines in Human Immunoglobulins by Microbial Transglutaminase.
    Spidel JL; Vaessen B; Albone EF; Cheng X; Verdi A; Kline JB
    Bioconjug Chem; 2017 Sep; 28(9):2471-2484. PubMed ID: 28820579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry.
    Wang L; Amphlett G; Blättler WA; Lambert JM; Zhang W
    Protein Sci; 2005 Sep; 14(9):2436-46. PubMed ID: 16081651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and structural characterization of therapeutic albumin chemical functionalization using complementary mass spectrometry techniques.
    Gahoual R; Bolbach G; Ould-Melha I; Clodic G; François YN; Scherman D; Mignet N; Houzé P
    J Pharm Biomed Anal; 2020 Jun; 185():113242. PubMed ID: 32169787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation.
    Matsuda Y; Malinao MC; Robles V; Song J; Yamada K; Mendelsohn BA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121981. PubMed ID: 32036254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
    Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
    Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    Anal Chem; 2014 Mar; 86(5):2657-64. PubMed ID: 24512515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system.
    Zimmerman ES; Heibeck TH; Gill A; Li X; Murray CJ; Madlansacay MR; Tran C; Uter NT; Yin G; Rivers PJ; Yam AY; Wang WD; Steiner AR; Bajad SU; Penta K; Yang W; Hallam TJ; Thanos CD; Sato AK
    Bioconjug Chem; 2014 Feb; 25(2):351-61. PubMed ID: 24437342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized conformational interrogation of antibody and antibody-drug conjugates by site-specific carboxyl group footprinting.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    MAbs; 2017; 9(2):307-318. PubMed ID: 27929747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.
    Beck A; Terral G; Debaene F; Wagner-Rousset E; Marcoux J; Janin-Bussat MC; Colas O; Van Dorsselaer A; Cianférani S
    Expert Rev Proteomics; 2016; 13(2):157-83. PubMed ID: 26653789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.